Literature DB >> 7356900

The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.

G G Skellern, B I Knight, C K Low, W D Alexander, D G McLarty, W J Kalk.   

Abstract

1 Methimazole plasma concentrations were measured in two groups of hyperthyroid subjects after the oral administration of either carbimazole or methimazole. 2 With the HPLC method it was also possible to measure the concentration of a methimazole metabolite, 3-methyl-2-thiohydantoin in one patient. 3 Large interindividual differences were observed, especially within the carbimazole group. 4 Incomplete absorption of carbimazole could explain particular high apparent volumes of distribution and apparent clearances.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356900      PMCID: PMC1429868          DOI: 10.1111/j.1365-2125.1980.tb05823.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Improved method for the determination of methimazole in plasma by high-performance liquid chromatography.

Authors:  G G Skellern; B I Knight; J B Stenlake
Journal:  J Chromatogr       Date:  1976-09-15

2.  Metabolism of 35S-labelled antithyroid drugs in man.

Authors:  W D Alexander; V Evans; A MacAulay; T F Gallagher; J Londono
Journal:  Br Med J       Date:  1969-05-03

3.  Proceedings: Changes in drug metabolizing ability in thyroid disease.

Authors:  J Crooks; A J Hedley; C Macnee; I H Stevenson
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

4.  Minimum effective dose of carbimazole.

Authors:  L C Low; T E Hilditch; W D Alexander
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

5.  Measurement of methimazole in human plasma using gas-liquid chromatography.

Authors:  M R Bending; D Stevenson
Journal:  J Chromatogr       Date:  1978-07-21

Review 6.  Antithyroid drugs.

Authors:  B Marchant; J F Lees; W D Alexander
Journal:  Pharmacol Ther B       Date:  1978

7.  Identification of 3-methyl-2-thiohydantoin, a metabolite of carbimazole, in man.

Authors:  G G Skellern; B I Knight; F M Luman; J B Stenlake; D G McLarty; M J Hooper
Journal:  Xenobiotica       Date:  1977-04       Impact factor: 1.908

8.  Antithyroid substances. 2. Some mercaptoglyoxalines, mercaptothiazoles and thiohydantoins.

Authors:  C E SEARLE; A LAWSON; H V MORLEY
Journal:  Biochem J       Date:  1951-06       Impact factor: 3.857

9.  Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.

Authors:  E S Vesell; J R Shapiro; T Passananti; H Jorgensen; C A Shively
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

10.  A new route to the imidazole-2-thiones from 2-thiohydantoins. Implications in the study of ergothioneine.

Authors:  J E Scott; G Henderson
Journal:  Biochem J       Date:  1968-09       Impact factor: 3.857

View more
  16 in total

1.  Associations of HLA genotypes with antithyroid drug-induced agranulocytosis: A systematic review and meta-analysis of pharmacogenomics studies.

Authors:  Wei-Ti Chen; Ching-Chi Chi
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

Review 2.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

3.  A survey of pharmacokinetic data from pregnant women.

Authors:  A J Cummings
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

Review 4.  Pharmacokinetics of antithyroid drugs.

Authors:  G Benker; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-06-01

5.  Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Authors:  B Hallengren; O R Nilsson; B E Karlberg; A Melander; L Tegler; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Intrathyroidal iodide binding rates and plasma methimazole concentrations in hyperthyroid patients on small doses of carbimazole.

Authors:  L C Low; D C McCruden; W D Alexander; T E Hilditch; G G Skellern; B I Knight
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

7.  The metabolism of methimazole in pregnancy.

Authors:  J Kampmann; J M Hansen
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

8.  Pharmacokinetic properties and bioavailability of methimazole.

Authors:  R Jansson; B Lindström; P A Dahlberg
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of antithyroid drugs.

Authors:  J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

10.  Pharmacokinetics of methimazole in humans.

Authors:  J H Hengstmann; H Hohn
Journal:  Klin Wochenschr       Date:  1985-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.